Literature DB >> 20213479

Comparison of optic nerve head topography findings in eyes with non-arteritic anterior ischemic optic neuropathy and eyes with glaucoma.

Josepha Horowitz1, Tagil Fishelzon-Arev, Eitan Z Rath, Eitan Segev, Orna Geyer.   

Abstract

BACKGROUND: To compare the peripapillary retinal nerve fiber layer (RNFL) thickness in eyes affected by non-arteritic ischemic optic neuropathy (NAION) or glaucoma as determined by optical coherence tomography (OCT).
METHODS: This cross-sectional institutional study included 18 eyes with NAION (at least 6 months since the acute event) and 29 eyes with glaucoma, both having localized visual field (VF) defects confined to one hemifield. Twenty-nine normal subjects served as controls. The fast RNFL thickness protocol (3.4) of the Stratus OCT (Carl Zeiss Meditec, Dublin, CA, USA) was used. The RNFL thickness and inferior maximum/temporal average (Imax/Tavg) and superior maximum/temporal average (Smax/Tavg) data corresponding to the hemifield with and without visual sensitivity loss were compared between NAION and glaucomatous eyes and with corresponding quadrants in normal eyes. The area under the receiver operating characteristic curve (AUC), sensitivities, and specificities were used to determine the OCT parameters that differ most in the two groups.
RESULTS: The mean RNFL thickness in the quadrants corresponding to the affected hemifield in the NAION and glaucomatous eyes was not significantly different (P > 0.9), but the values for both were decreased compared to the control eyes (P < 0.0001). The mean RNFL thickness in the quadrant corresponding to the unaffected hemifield was significantly lower in the glaucomatous eyes (73.8 +/- 20.04 micro) than in the NAION eyes (96.6 +/- 23.32 micro, P = 0.023), and in both study groups compared to the controls (117.2 +/- 13.44 micro, P < 0.0001 for glaucomatous vs control eyes, and P < 0.025 for NAION vs control eyes). Smax/Tavg and Imax/Tavg of the quadrant corresponding to the unaffected hemifield had the strongest power to differentiate the two diseases (an AUC of 0.92).
CONCLUSIONS: Stratus OCT detected significant quantitative differences in RNFL thickness between glaucomatous and NAION eyes, both conditions with hemifield defects. These differences might hold a clue in understanding the processes involved in optic nerve injury.

Entities:  

Mesh:

Year:  2010        PMID: 20213479     DOI: 10.1007/s00417-010-1323-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  19 in total

1.  Relationship between retinal nerve fiber layer and visual field sensitivity as measured by optical coherence tomography in chiasmal compression.

Authors:  Helen V Danesh-Meyer; Stuart C Carroll; Rod Foroozan; Peter J Savino; Jennifer Fan; Yannan Jiang; Stephen Vander Hoorn
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-11       Impact factor: 4.799

2.  Structure versus function in glaucoma: an application of a linear model.

Authors:  Donald C Hood; Susan C Anderson; Michael Wall; Randy H Kardon
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

3.  Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT.

Authors:  Donald L Budenz; Douglas R Anderson; Rohit Varma; Joel Schuman; Louis Cantor; Jonathan Savell; David S Greenfield; Vincent Michael Patella; Harry A Quigley; James Tielsch
Journal:  Ophthalmology       Date:  2007-01-08       Impact factor: 12.079

Review 4.  Optical coherence tomography: a new tool for glaucoma diagnosis.

Authors:  J S Schuman; M R Hee; A V Arya; T Pedut-Kloizman; C A Puliafito; J G Fujimoto; E A Swanson
Journal:  Curr Opin Ophthalmol       Date:  1995-04       Impact factor: 3.761

5.  Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination.

Authors:  Sohan Singh Hayreh; Bridget Zimmerman
Journal:  Arch Ophthalmol       Date:  2005-11

6.  Different strategies for Humphrey automated perimetry: FASTPAC, SITA standard and SITA fast in normal subjects and glaucoma patients.

Authors:  X Roggen; K Herman; L Van Malderen; M Devos; W Spileers
Journal:  Bull Soc Belge Ophtalmol       Date:  2001

7.  Nerve fiber layer thickness in glaucoma patients with asymmetric hemifield visual field loss.

Authors:  Vandana Badlani; Mahnaz Shahidi; Akbar Shakoor; Deepak P Edward; Ruth Zelkha; Jacob Wilensky
Journal:  J Glaucoma       Date:  2006-08       Impact factor: 2.503

8.  Retinal nerve fiber structure versus visual field function in patients with ischemic optic neuropathy. A test of a linear model.

Authors:  Donald C Hood; Susan Anderson; Jacinthe Rouleau; Adam S Wenick; Larissa K Grover; Myles M Behrens; Jeffrey G Odel; Andrew G Lee; Randy H Kardon
Journal:  Ophthalmology       Date:  2007-09-17       Impact factor: 12.079

9.  Optic disc evaluation by optical coherence tomography in nonarteritic anterior ischemic optic neuropathy.

Authors:  Inés Contreras; Gema Rebolleda; Susana Noval; Francisco J Muñoz-Negrete
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

10.  Retinal nerve fiber layer measures in high- and normal-tension glaucoma.

Authors:  Evgenia Konstantakopoulou; Barnaby C Reeves; Cecilia Fenerty; Robert A Harper
Journal:  Optom Vis Sci       Date:  2008-07       Impact factor: 1.973

View more
  10 in total

Review 1.  Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.

Authors:  Kristin M Galetta; Peter A Calabresi; Elliot M Frohman; Laura J Balcer
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Optical coherence tomography study of experimental anterior ischemic optic neuropathy and histologic confirmation.

Authors:  Joyce K Ho; Madison P Stanford; Mohammad A Shariati; Roopa Dalal; Yaping Joyce Liao
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-05       Impact factor: 4.799

3.  Optical coherence tomography evaluation of retinal nerve fiber layer thickness in non-arteritic anterior ischemic optic neuropathy and primary open angle glaucoma: a systematic review and Meta-analysis.

Authors:  Yu-Xin Tong; Xin-Yu Zhang; Yi He; Zong-Lin Chen; Bing Jiang
Journal:  Int J Ophthalmol       Date:  2022-08-18       Impact factor: 1.645

4.  Glaucoma masqueraders: Diagnosis by spectral domain optical coherence tomography.

Authors:  Jullia A Rosdahl; Sanjay Asrani
Journal:  Saudi J Ophthalmol       Date:  2012-10

5.  Long-term retinal nerve fiber layer changes following nonarteritic anterior ischemic optic neuropathy.

Authors:  Gad Dotan; Michaella Goldstein; Anat Kesler; Barry Skarf
Journal:  Clin Ophthalmol       Date:  2013-04-17

6.  Change of retinal nerve fiber layer thickness in patients with nonarteritic inflammatory anterior ischemic optic neuropathy.

Authors:  Tingting Liu; Hongsheng Bi; Xingrong Wang; Guimin Wang; Haiyan Li; Hui Wu; Yi Qu; Ying Wen; Chenyang Cong; Daoguang Wang
Journal:  Neural Regen Res       Date:  2012-12-15       Impact factor: 5.135

7.  Comparison of optic nerve morphology in eyes with glaucoma and eyes with non-arteritic anterior ischemic optic neuropathy by Fourier domain optical coherence tomography.

Authors:  Yuxin Yang; Haitao Zhang; Yitao Yan; Yanling Gui; Tiechui Zhu
Journal:  Exp Ther Med       Date:  2013-05-15       Impact factor: 2.447

8.  Differences between Non-arteritic Anterior Ischemic Optic Neuropathy and Open Angle Glaucoma with Altitudinal Visual Field Defect.

Authors:  Sangyoun Han; Jong Jin Jung; Ungsoo Samuel Kim
Journal:  Korean J Ophthalmol       Date:  2015-11-25

9.  Difference in patterns of retinal ganglion cell damage between primary open-angle glaucoma and non-arteritic anterior ischaemic optic neuropathy.

Authors:  Yeon Hee Lee; Kyoung Nam Kim; Dong Won Heo; Tae Seen Kang; Sung Bok Lee; Chang-Sik Kim
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

10.  Are All Retinal Nerve Fiber Layer Defects on Optic Coherence Tomography Glaucomatous?

Authors:  Sirel Gür Güngör; Akman Ahmet
Journal:  Turk J Ophthalmol       Date:  2017-10-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.